Highly Active Antiretroviral Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Mochudi Prevention Project ART Protocol
Condition: HIV InfectionsIntervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, EmtricitabineSponsors: Harvard School of Public Health; National Institute of Allergy and Infectious Diseases (NIAID)Terminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2012 Category: Research Source Type: clinical trials
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Condition: HIVInterventions: Genetic: SB-728-T; Genetic: SB-728-T; Genetic: SB-728-T; Genetic: SB-728-T; Genetic: SB-728-TSponsor: Sangamo BiosciencesRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2012 Category: Research Source Type: clinical trials
Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy
Condition: TuberculosisIntervention: Sponsors: Centre for the AIDS Programme of Research in South Africa; Presidents Emergency Plan for AIDS Relief; Howard Hughes Medical Institute; K-RITHActive, not recruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2012 Category: Research Source Type: clinical trials
